A Multicenter Study on the Prognostic Value of Indicators Derived From Complete Blood Count in Glioblastoma
Mediators of Inflammation · 2025-01 · 2025 (1)
DOI: 10.1155/mi/5588098 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Mediators of Inflammation, online erschienen am 10.12.2025. Verfasst von Shiqiang Hou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Affiliated Chuzhou Hospital of Anhui Medical University, The First People's Hospital of Chuzhou, Chuzhou, 239000, Chi…. Hauptthemen laut MEDLINE: Glioblastoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Foundation of Education Department of Anhui Province of China, Chuzhou Science and Technology Program.
Abstract (Originalsprache)
Background
Previous studies have found that some indices derived from preoperative complete blood count (CBC) are closely related to the prognosis of glioma, but the results are inconsistent. This study comprehensively discussed the prognostic significance of the preoperative CBC index in patients with glioblastoma (GBM) through a multicenter study.
Methods
In this multicenter study, we retrospectively analyzed clinical data from 143 GBM patients to evaluate the prognostic value of 12 preoperative CBC‐derived indicators: Neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), monocyte‐to‐lymphocyte ratio (MLR), red cell distribution width (RDW), platelet distribution width (PDW), RDW‐to‐PDW (RPR), systemic inflammation index (SII), systemic inflammation response index (SIRI), hemoglobin‐to‐red cell distribution width ratio (HRR), platelet‐to‐basophil ratio (PBR), lymphocyte‐to‐basophil ratio (LBR), and eosinophil‐to‐lymphocyte ratio (ELR). Optimal cut‐off values for each indicator were determined using maximally selected rank statistics (MSRS). Survival outcomes were assessed by Kaplan–Meier analysis, and univariate and multivariate Cox regression were employed to identify independent prognostic factors. Furthermore, a nomogram was developed by integrating significant prognostic indicators to facilitate individualized prediction of survival in GBM patients.
Results
The results showed that higher levels of NLR, PLR, MLR, RDW, PDW, and RPR were associated with shorter survival in GBM patients. In contrast, lower levels of ELR were associated with shorter survival in GBM patients. Among these, RDW (HR 1.905, 95% CI 1.114–3.258, p = 0.019), MLR (HR 1.603, 95% CI 1.029–2.496, p = 0.037), and ELR (HR 0.380, 95% CI 0.193–0.747, p = 0.005) emerged as an independent prognostic factors. The prognostic nomogram was constructed according to the three independent factors, which improved the accuracy of prognosis prediction (AUC = 0.702).
Conclusion
Routine preoperative CBC parameters, particularly RDW, MLR, and ELR, serve as valuable complementary prognostic indicators for GBM patients. These accessible biomarkers warrant further validation through large‐sample, multicenter studies to solidify their clinical utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, The Affiliated Chuzhou Hospital of Anhui Medical University, The First People's Hospital of Chuzhou, Chuzhou, 239000, China.
- School of Public Health, Nantong University, Nantong, China, ntu.edu.cn.
- Laboratory Medicine Center, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China, jsph.net.
- Laboratory Medicine Center, The Affiliated Chuzhou Hospital of Anhui Medical University, The First People's Hospital of Chuzhou, Chuzhou, 239000, China.
ORCID-Profile: Shiqiang Hou, Qihong Gu, Tao Yang, Yiwen Hou, Min Wang, Yu Pan, Chunjing Jin, Ning Lin
Förderung
- Scientific Research Foundation of Education Department of Anhui Province of China
- Chuzhou Science and Technology Program
Zitieren
APA
Hou, S., Gu, Q., Yang, T., Hou, Y., Wang, M., Pan, Y., Jin, C., & Lin, N. (2025). A Multicenter Study on the Prognostic Value of Indicators Derived From Complete Blood Count in Glioblastoma. Mediators of Inflammation, 2025(1). https://doi.org/10.1155/mi/5588098
Vancouver
Hou S, Gu Q, Yang T, Hou Y, Wang M, Pan Y, et al. A Multicenter Study on the Prognostic Value of Indicators Derived From Complete Blood Count in Glioblastoma. Mediators of Inflammation. 2025;2025(1). doi:10.1155/mi/5588098
BibTeX
@article{Hou2025,
author = {Hou, Shiqiang and Gu, Qihong and Yang, Tao and Hou, Yiwen and Wang, Min and Pan, Yu and Jin, Chunjing and Lin, Ning},
title = {A Multicenter Study on the Prognostic Value of Indicators Derived From Complete Blood Count in Glioblastoma},
journal = {Mediators of Inflammation},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/mi/5588098}
}
EUVIMED